LGALS3 and hepatocellular carcinoma: Meanwhile, the serum level of LGALS3 in HCC‐BM patients was significantly higher than that in HCC patients without bone‐metastasis (Figure 3F), suggestive of serum LGALS3 level as a potential biomarker for HCC‐BM.